Kopra Bio

Genetically engineered viruses that teach your immune system to kill cancer

Company details
Company
Kopra Bio
Stage
Seed

About

Kopra Bio

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using technology developed at UCSF. The company is making the next Keytruda, a $25B/yr cancer drug blockbuster, starting with the most aggressive form of brain cancer, glioblastoma. In preclinical models, their approach improves survival rates from 0% with the FDA-approved standard-of-care treatment to greater than 90% long-term survival with our treatment.

Our portfolio

Boutique Venture Partners backs authentic founders who transform industries and create new ones in healthcare and life sciences.